![]() |
市場調査レポート
商品コード
1776218
半月板修復システムの世界市場 - 市場考察、競合情勢、市場予測(2032年)Meniscus Repair Systems - Market Insights, Competitive Landscape, and Market Forecast - 2032 |
||||||
カスタマイズ可能
適宜更新あり
|
半月板修復システムの世界市場 - 市場考察、競合情勢、市場予測(2032年) |
出版日: 2025年07月01日
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
|
世界の半月板修復システムの市場規模は、2024年に5億642万米ドルであり、2032年までに7億8,643万米ドルに達すると予測され、2025年~2032年の予測期間にCAGRで5.69%の成長が見込まれます。半月板修復システムの需要は、複数の重大な要因によって増加傾向にあります。これらには、スポーツや骨に関連した怪我による筋骨格系疾患の罹患率の増加や、老年人口の増加などの危険因子が含まれます。さらに、小さな切開と特殊な器具の使用によって半月板断裂にアクセスし修復する、低侵襲半月板修復術に対する認識と選好の高まりもあります。さらに、主な市場参入企業による製品開発や新製品の上市の増加もこの成長に寄与しています。これらの動向が持続的拡大に有利な環境を作り出しており、半月板修復システム市場は2025年~2032年の予測期間を通じて健全かつ安定した成長を示す見通しです。
半月板修復システムの市場力学
世界保健機関(WHO)(2023)によると、世界全体で3億4,400万人を超える人々が変形性関節症に罹患し、2022年に約17億1,000万人が筋骨格系障害に苦しんでいます。
英国では、National Institute for Health and Care Research(2024)が、2024年に約70万人が関節リウマチ(RA)に罹患していると推定しています。同様に、Australian Bureau of Statisticsのデータによると、2022年に人口の14.5%を占める370万人を超えるオーストラリア人が関節炎を患っています。ドイツでは、National Institute of Health(2023)のレポートによると、年間100万人を超える患者が変形性膝関節症と診断されています。このような筋骨格系疾患の患者は世界的に増加しており、これらの疾患の治療に用いる半月板修復デバイスの需要を生み出しています。
関節炎や変形性膝関節症の有病率の増加は、半月板修復デバイスの需要を大きく促進しています。関節を温存する、従来の外科的アプローチよりも低侵襲な治療がますます好まれるようになるにつれて、半月板修復による早期介入が人気を集めています。これらの手技は、膝の機能を維持するだけでなく、疾患の進行を遅らせ、患者の長期的な転帰の向上に寄与するため、半月板修復システムの市場全体を押し上げます。
さらに、米国国立衛生研究所(2023)のデータによると、米国では年間約40万件のACL再建術が行われています。半月板損傷はACL断裂を伴うことが多いため、半月板修復デバイスはこれらの手術で頻繁に利用されています。これらのデバイスは、縫合糸を完全に関節内に留置するように設計されており、半月板線維に沿った放射状の断裂に特に効果的です。ACL再建術との併用が需要をさらに押し上げ、半月板修復デバイス市場の成長に大きく寄与しています。
加えて、特に活動的な若者の間では、スポーツによる怪我が半月板損傷の主因となっています。Australian Institute of Health and Welfare(2024)によると、2022年だけで約5万6,000件のスポーツ傷害が入院につながっています。同様に、ドイツのNational Institute of Health(2023)のデータでは、年間200万件を超えるスポーツ傷害が報告されています。このようにスポーツに関連した外傷の罹患率が上昇しており、しばしば半月板断裂を引き起こしていることから、効果的な修復ソリューションに対するニーズが高まっています。
このような傷害の頻度の増加は、アスリートがより早い回復と身体活動への素早い復帰を求めることから、半月板修復システムの採用を加速させています。
さらに、市場の主要企業は半月板断裂の治療効果を高める革新的なデバイスの開発に積極的に投資しており、これが市場の成長をさらに後押ししています。例えば2024年10月、Regenity Biosciencesは、低侵襲のコラーゲンベースの半月板インプラントであるRejuvaKneeTMのFDA 510(k)認可を取得したと発表しました。この先進のデバイスは、半月板の軟部組織の損傷を補強し修復するように設計されており、関節を温存する治療オプションを求める患者に斬新なソリューションを提供します。このような進歩により、治療領域が拡大し、半月板修復システムの採用が世界中で加速しています。
当レポートでは、世界の半月板修復システム市場について調査分析し、市場規模と予測、過去3年の製品/技術開発、市場の主要企業、利用可能な機会などの情報を提供しています。
Meniscus Repair Systems Market by Product Type (All-Inside Repair System, Inside-Out Repair System, Outside-In Repair System, and Meniscal Root Repair System), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the rising cases of musculoskeletal conditions and associated risk factors, increasing preference for minimally invasive meniscus repairs, and increasing product development and launches activities by key players.
The meniscus repair systems market was valued at USD 506.42 million in 2024, growing at a CAGR of 5.69% during the forecast period from 2025 to 2032 to reach USD 786.43 million by 2032. The demand for meniscus repair systems is on the rise, driven by several key factors. These include the growing incidence of musculoskeletal conditions caused by sports and bone-related injuries, as well as risk factors such as a growing aging population and others. Additionally, the increasing awareness and preference for minimally invasive meniscus repair procedures, which involve small incisions and the use of specialized instruments to access and repair the torn meniscus. Moreover, increasing product development and new product launches by key market players are contributing to this growth. Together, these trends are creating a favorable environment for sustained expansion, positioning the meniscus repair systems market for robust and consistent growth throughout the forecast period from 2025 to 2032.
Meniscus Repair Systems Market Dynamics:
According to the World Health Organization (2023), over 344 million individuals were affected by osteoarthritis globally, while approximately 1.71 billion people suffered from musculoskeletal disorders in 2022.
In the UK, the National Institute for Health and Care Research (2024), estimated that around 700,000 people were living with rheumatoid arthritis (RA) in 2024. Similarly, data from the Australian Bureau of Statistics showed that more than 3.7 million Australians, accounting for 14.5% of the population, had arthritis in 2022. In Germany, the National Institute of Health (2023) reported that over 1 million patients are diagnosed annually with knee osteoarthritis. Such cases of musculoskeletal conditions are increasing worldwide which is creating the demand for meniscus repair devices for the treatment of these conditions.
The growing prevalence of arthritis and knee osteoarthritis is significantly driving demand for meniscal repair devices. As joint-preserving, minimally invasive treatments become increasingly preferred over traditional surgical approaches, early intervention through meniscal repair is gaining traction. These procedures not only help preserve knee function but also slow disease progression, contributing to improved long-term outcomes for patients thereby boosting the overall market of meniscus repair system.
Moreover, according to data from the National Institute of Health (2023), approximately 400,000 ACL reconstruction procedures were performed annually in the United States. Meniscus repair devices are frequently utilized during these procedures, as meniscal injuries often accompany ACL tears. These devices, designed to place sutures entirely within the joint, are especially effective in treating radial tears along the meniscus fibers. Their use in conjunction with ACL reconstruction is further boosting demand, thereby contributing significantly to the growth of the meniscus repair devices market.
In addition, sports injuries remain a major contributor to meniscal damage, particularly among young and active individuals. According to the Australian Institute of Health and Welfare (2024), approximately 56,000 sports-related injuries resulted in hospital stays in 2022 alone. Similarly, data from Germany's National Institute of Health (2023) reported over 2 million sports injuries annually. This rising incidence of sports-related trauma, which often leads to meniscal tears, is creating a growing need for effective repair solutions.
The increasing frequency of such injuries is accelerating the adoption of meniscus repair systems, as athletes seek faster recovery and quicker return to physical activity.
Moreover, leading players in the market are actively investing in the development of innovative devices to enhance the effectiveness of meniscus tear treatments, which is further propelling market growth. For instance, in October 2024, Regenity Biosciences announced that it had received FDA 510(k) clearance to market RejuvaKneeTM, a minimally invasive, collagen-based meniscal implant. This advanced device is designed to reinforce and repair soft tissue injuries of the meniscus, offering a novel solution for patients seeking joint-preserving treatment options. Such advancements are expanding the therapeutic landscape and accelerating the adoption of meniscus repair systems worldwide.
Collectively, the rising burden of arthritis, the surge in sports injuries, and the growing preference for minimally invasive, joint-preserving techniques are expected to fuel strong and sustained growth in the global meniscus repair systems market throughout the forecast period from 2025 to 2032.
However, the risk of postoperative complications associated with meniscus repair devices and the high cost of procedure and devices, among others are some of the key constraints that may limit the growth of the meniscus repair systems market.
Meniscus Repair Systems Market Segment Analysis:
Meniscus Repair Systems Market by Product Type (All-Inside Repair System, Inside-Out Repair System, Outside-In Repair System, and Meniscal Root Repair System), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product type segment of the meniscus repair systems market, the all-inside repair system category is estimated to account for the largest market share in 2024. The growth of this category is primarily fueled by the rising incidence of sports-related and traumatic knee injuries, combined with the growing clinical adoption and expanded applications of all-inside meniscus repair devices.
All-inside repair devices offer a minimally invasive solution for meniscal repair, requiring fewer incisions and causing less disruption to surrounding soft tissues. This translates to several key patient benefits, including reduced postoperative pain, faster recovery times, and minimal scarring. Since the entire procedure is performed within the joint capsule, the risk of neurovascular injury such as damage to the saphenous or peroneal nerves and adjacent blood vessels, is significantly reduced.
Moreover, these systems eliminate the need for posterior incisions and reduce reliance on accessory instrumentation, thereby lowering the risk of complications, including infections and prolonged recovery periods. Their design allows surgeons to effectively access and treat complex tear locations such as the posterior horn, and mid-body, and select anterior horn tears, making them particularly valuable for anatomically challenging cases.
Some of the key products in this category underscore the value of innovation in driving market growth. For example, the TRUESPANTM meniscal repair system by Johnson & Johnson MedTech is engineered to simplify and streamline the repair process. Similarly, the FAST-FIX 360 all-inside system by Smith+Nephew offers quick, reproducible implant deployment, smaller insertion points, and enhanced control enabling surgeons to optimize knee function and joint stability while preserving as much of the native meniscus as possible.
Thus, the factors mentioned above are likely to boost the market segment and thereby increase the overall market of meniscus repair systems across the globe.
North America is expected to dominate the overall meniscus repair systems market:
North America is expected to hold the largest share of the meniscus repair systems market in 2024, among all other regions. This dominance is primarily driven by the increasing prevalence of musculoskeletal conditions especially within the aging population along with growing awareness and preference for minimally invasive meniscus repair procedures. Additionally, continuous advancements in product development and regulatory approvals are further contributing to the region's leading position.
According to the Centers for Disease Control and Prevention (CDC), in 2024, approximately 53 million adults in the U.S. were living with arthritis, a number expected to rise significantly as the population ages. Similarly, the Arthritis Society Canada reported that about 6 million people (1 in 5 adults) were affected by arthritis in Canada in 2024. Additionally, data from the National Institutes of Health (NIH, 2023) revealed that over 4 million Canadians were diagnosed with knee osteoarthritis in 2023.
This rising prevalence of arthritis and knee osteoarthritis is significantly driving the growth of the meniscus repair device market in North America. These chronic joint conditions often lead to meniscal damage, fueling the demand for surgical interventions and advanced repair technologies.
Compounding this demand is the high incidence of acute knee injuries. The National Safety Council (2023), reported that 3.7 million individuals were treated in emergency departments for sports and recreational injuries in the United States. This growing burden of both chronic and acute knee conditions is increasing the adoption of meniscus repair devices, particularly minimally invasive systems that enable quicker recovery and joint preservation.
Supporting this trend, a recent study published by the American Academy of Orthopaedic Surgeons (2023), highlighted that over 700,000 meniscal procedures were performed annually in the United States, underscoring the high procedural volume and continued need for effective meniscus repair solutions.
The market growth is further strengthened by continuous product innovation and favorable regulatory advancements. For example, in April 2025, Native Orthopedics, Inc. received FDA clearance for its groundbreaking Native Root System powered by DragonflyTM an advanced solution specifically developed for meniscal root repair. This system features two single-use, sterile-packed dragonfly devices, meticulously designed to reapproximate a torn meniscal root to its native anatomical footprint, thereby supporting more precise, efficient, and durable surgical outcomes.
Collectively, the rising burden of joint diseases, increasing sports-related injuries, growing procedural volumes, and the launch of innovative repair solutions are expected to drive robust growth in the North American meniscus repair systems market throughout the forecast period from 2025 to 2032.
Meniscus Repair Systems Market Key Players:
Some of the key market players operating in the meniscus repair systems market include Stryker, Johnson & Johnson Services, Inc., Smith+Nephew, Arthrex, Inc., Biotek, Zimmer Biomet, CONMED Corporation, Abanzamed, Native Orthopaedics, Regenity, NovoPedics, Inc., Auxein, CHANGZHOU MEDITECH TECHNOLOGY CO., LTD., Atro Medical B.V., Arcuro Medical, OrthoPreserve, Healthium Medtech Limited, and others.
Recent Developmental Activities in the Meniscus Repair Systems Market:
Key takeaways from the meniscus repair systems market report study
Target audience who can benefit from this meniscus repair systems market report study
Frequently Asked Questions for the Meniscus Repair Systems Market: